Life Sciences Team

Business Development

Senior Director

Phone: 650.543.8202

Ms. Baker has over 30 years of financial experience, focusing predominantly on the healthcare industry. She is responsible for originating financings for life sciences companies, primarily in western North America. Before joining Oxford, Ms. Baker was executive vice president for Capital Advisors Group, providing investment management services primarily to public and private life sciences and medical device companies. She also held positions as regional business development director for Questpoint, treasurer for MFS Intelenet, assistant treasurer at ASK Computer Systems, vice president of Corporate Finance and Debt for Sierra Capital Companies and treasurer for Consolidated Capital, which operated five publicly traded REITS and 22 real estate limited partnerships. Ms. Baker received a B.A. in Speech Communications and an M.B.A. from University of Denver.

Senior Director

Phone: 617.849.9046

Mr. Chabot joined Oxford in 2002 and serves clients in New England, New York and eastern Canada. He is responsible for the origination of loans in the life sciences area and maintains relationships with venture capitalists to support the debt needs of their portfolio companies. Mr. Chabot has been in the venture lending field for over 15 years, starting with his position at LINC, heading up its East Coast office. After leaving LINC in 1999, he founded CTT Financial and was an advisor to venture-backed companies looking for equipment financing. He received a B.A. from Trinity College, with honors in Economics and History.
Senior Director

Phone: 858.997.1434

Dr. Sanborn has over 20 years of experience in this industry as a venture debt lender and equity investor, banker, executive and entrepreneur. Currently, she is responsible for originating life sciences deals, primarily in Western North America. Her previous positions include managing director at Hercules Technology Growth Capital, senior vice president of Comerica Bank, principal/fund manager at IngleWood Ventures, director of Technology Commercialization at Stratagene and vice president of Business Development at Phenogenex. Over the years, Dr. Sanborn has also advised entrepreneurial boards, investment funds and management teams on operational, financial and strategic matters. She received a Ph.D. in Molecular Biology from Cornell University/Sloan-Kettering Institute.
Senior Director

Phone: 703.519.6082

Mr. Soller has over 15 years of senior lending experience, with 12 of them in the life sciences industry. In addition to managing relationships with investors, bankers and advisors, he is responsible for originations in Australia, Europe, Israel and a majority of the United States (Mid-Atlantic, Midwest, Rocky Mountains, Southeast and Southwest regions).

He joined Oxford Finance as a member of its Credit & Portfolio team in 2006 and transitioned to the Business Development team in 2008. During his time at Oxford he has originated, structured and underwrote over $1 billion in debt facilities for venture-backed and publicly-listed life sciences companies.

Prior to joining Oxford, Mr. Soller was an analyst in the Acquisitions Group of Capital Automotive, a real estate investment trust, where he underwrote over $1 billion in transactions and managed a portion of a $2.5 billion portfolio. He holds a B.A. in Economics and Business, with a concentration in Financial Management from the Virginia Military Institute.

Credit & Portfolio Management

Garrett Henn
Executive Director, Credit & Portfolio Management
Mr. Henn has over 10 years of commercial lending experience to public and venture-backed life sciences and technology companies. He became part of the Oxford team in 2008, and is responsible for overseeing the firm’s portfolio of loans in western United States and western Canada. Prior to joining Oxford, Mr. Henn held various positions at Silicon Valley Bank where he managed a portfolio of loans primarily comprised of early and late-stage life sciences and technology companies. He holds a B.S. in Business Administration with a concentration in Finance from California State University, Los Angeles.
Executive Director, Credit & Portfolio Management
Ms. Wittman has been meeting the financing and advisory needs of growth-oriented companies in the healthcare and technology industries for nearly 15 years. Currently, she manages Oxford’s portfolio of loans and investments made to companies based in the eastern United States, Canada and Europe. Before joining Oxford, she was a senior analyst at WWC Capital Group (Outcome Capital), an investment bank that provides M&A advisory services and raises capital for venture-backed and middle-market technology companies. Ms. Wittman received a B.S. in Commerce with a concentration in Finance from the University of Virginia.

Providing Flexible and Creative Financial Solutions to Life Sciences and Healthcare Services Companies